ENST00000499452 competitively inhibits miR-27a through the same mechanism, accordingly weakening its inhibitory effect on CXCL1 and strengthening the immune response and inflammatory response and even fibrosis in OFs in TAO patients. The gene discussed is CXCL1; the disease is thromboangiitis obliterans.